To test whether mTOR inhibition affects the effectiveness of temozolomide chemotherapy in glioblastoma cells, LN-308, LNT-229 and G55T2 cells were treated with temozolomide in the presence of rapamycin or torin2. This evidence concerns the gene MTOR and glioblastoma.